APRE logo

Aprea Therapeutics (APRE) Company Overview

Profile

Full Name:

Aprea Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 3, 2019

Indexes:

Not included

Description:

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of anti-cancer drugs that reactivate the mutant tumor suppressor protein p53. Its lead candidate product, APR-246, is a low molecular weight reactivator of p53 that is in late-stage clinical development for the treatment of hematologic malignancies, including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). The company was founded in 2006 and is headquartered in Boston, Massachusetts.

Events Calendar

Earnings

Next earnings date:

Mar 26, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 26, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Feb 13, 2023

Analyst ratings

Recent major analysts updates

Jan 15, 25 HC Wainwright & Co.
Buy
Dec 17, 24 HC Wainwright & Co.
Buy
Nov 18, 24 HC Wainwright & Co.
Buy
Oct 24, 24 HC Wainwright & Co.
Buy
Aug 13, 24 Wedbush
Outperform
Aug 12, 24 HC Wainwright & Co.
Buy
Jun 24, 24 HC Wainwright & Co.
Buy
Jun 17, 24 HC Wainwright & Co.
Buy
May 14, 24 HC Wainwright & Co.
Buy
Mar 27, 24 Wedbush
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Aprea Therapeutics?
  • Does Aprea Therapeutics pay dividends?
  • What sector is Aprea Therapeutics in?
  • What industry is Aprea Therapeutics in?
  • What country is Aprea Therapeutics based in?
  • When did Aprea Therapeutics go public?
  • Is Aprea Therapeutics in the S&P 500?
  • Is Aprea Therapeutics in the NASDAQ 100?
  • Is Aprea Therapeutics in the Dow Jones?
  • When was Aprea Therapeutics's last earnings report?
  • When does Aprea Therapeutics report earnings?
  • Should I buy Aprea Therapeutics stock now?

What is the ticker symbol for Aprea Therapeutics?

The ticker symbol for Aprea Therapeutics is NASDAQ:APRE

Does Aprea Therapeutics pay dividends?

No, Aprea Therapeutics does not pay dividends

What sector is Aprea Therapeutics in?

Aprea Therapeutics is in the Healthcare sector

What industry is Aprea Therapeutics in?

Aprea Therapeutics is in the Biotechnology industry

What country is Aprea Therapeutics based in?

Aprea Therapeutics is headquartered in United States

When did Aprea Therapeutics go public?

Aprea Therapeutics's initial public offering (IPO) was on October 3, 2019

Is Aprea Therapeutics in the S&P 500?

No, Aprea Therapeutics is not included in the S&P 500 index

Is Aprea Therapeutics in the NASDAQ 100?

No, Aprea Therapeutics is not included in the NASDAQ 100 index

Is Aprea Therapeutics in the Dow Jones?

No, Aprea Therapeutics is not included in the Dow Jones index

When was Aprea Therapeutics's last earnings report?

Aprea Therapeutics's most recent earnings report was on Nov 7, 2024

When does Aprea Therapeutics report earnings?

The next expected earnings date for Aprea Therapeutics is Mar 26, 2025

Should I buy Aprea Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions